Results
dilated CBD
MALIGNANT DISEASE
Between September 2017 and December 2019, a total of 70 patients were assessed for eligibility. Eighteen patients were excluded from the study (11 patients had malignant disease, 5 had dilated CBD > 20mm and 2 patients refused the study). Fifty-two patients were randomly assigned to RYHJ-C (Endoscopic view in a patient who underwent biliary reconstruction with gastric access loop. 